A new formula for evaluating culprit lesion characteristics in STEMI patients based on baseline

Rui Gao1,2,3, Qi Liu1,2,3, Jingbo Hou1,2,3

  • 1Harbin Medical University, China.

Insights

A new formula, NGSA2/P2, helps predict plaque characteristics in ST-segment elevation myocardial infarction patients. This comprehensive approach improves risk stratification and guides precision management for better patient outcomes.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Translational Medicine

Background:

  • Acute myocardial infarction (AMI) is a major global health concern.
  • ST-segment elevation myocardial infarction (STEMI) patients present with diverse plaque morphologies.
  • Current risk stratification methods for STEMI require enhancement for personalized management.

Purpose of the Study:

  • To develop and validate a novel formula (NGSA2/P2) for predicting coronary artery plaque characteristics in STEMI patients.
  • To assess the formula's efficacy in improving risk stratification compared to single-factor assessments.
  • To facilitate precision management strategies for STEMI patients.

Main Methods:

  • A cohort of 268 STEMI patients undergoing optical coherence tomography was analyzed.
  • A new formula, NGSA2/P2 = ln((non-HDL cholesterol / HDL cholesterol) * HbA1c * SBP * Age^2 / Platelet Count^2), was derived.
  • Patients were categorized into three groups (T0, T1, T2) based on NGSA2/P2 values.

Main Results:

  • Patients with plaque rupture were older, had lower platelet counts, and higher NGSA2/P2 values compared to those with plaque erosion.
  • Plaque rupture showed positive correlations with age and NGSA2/P2, and negative correlation with platelet count.
  • Higher NGSA2/P2 groups (T1, T2) exhibited increased markers of vulnerable plaque, including cholesterol crystals and thin-cap fibroatheromas.

Conclusions:

  • The NGSA2/P2 formula offers superior prediction of plaque characteristics over single factors in STEMI.
  • This formula aids in comprehensive risk stratification and personalized treatment approaches.
  • For elderly STEMI patients, managing lipids, blood pressure, glucose, and platelet counts is crucial.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
804
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
213
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
354